Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.17
-0.06 (-1.86%)
At close: Sep 04, 2025, 3:59 PM
3.15
-0.61%
After-hours: Sep 04, 2025, 04:34 PM EDT
-1.86% (1D)
| Bid | 3.1 |
| Market Cap | 122.3M |
| Revenue (ttm) | 332K |
| Net Income (ttm) | -50.86M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -2.03 |
| Forward PE | -1.93 |
| Analyst | Buy |
| Ask | 3.3 |
| Volume | 140,901 |
| Avg. Volume (20D) | 290,622 |
| Open | 3.25 |
| Previous Close | 3.23 |
| Day's Range | 3.15 - 3.29 |
| 52-Week Range | 1.59 - 10.48 |
| Beta | 1.42 |
About TARA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-18.52%
Protara Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
4 months ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.
